Regulatory Reforms: Ecuador

Corral Rosales

Francisco Gallegos

Felipe Samaniego

Eduardo Rios

Miguel Maigualema

Regulatory Reforms

01/10/2024

Corral Rosales / Ecuador

1. Are there proposals for reform or significant change to the healthcare system?

Since former president Lenin Moreno vetoed the Health Code bill (September 2020), no developments have occurred.

2. When are they likely to come into force?

Uncertain.

<

Also From This Contributor

Regulatory, Pricing and Reimbursement: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. What are the regulatory authorities with jurisdiction over drugs, biologicals, and medical devices in your country? The National Agency for Regulation, Control, and Sanitary Surveillance (ARCSA), a decentralized Health Ministry (HM) agency, is responsible for applying and enforcing the regulatory framework regarding human medicines, biologicals, and medical devices. 2. What is the regulatory framework for the authorization, pricing, and reimbursement of drugs, biologicals, and medical devices? The primary legislation for the authorization, pricing, and reimbursement of medicines, biologicals, and medical devices…

Preclinical and Clinical Trial Requirements: Ecuador

01/10/2024

Corral Rosales

Ecuador

As a general introduction, clinical trials are regulated in Ecuador via the Ministerial Agreement (MA) 0075-2017 and reform 0006-2020, which relates to regulations for approving, developing, monitoring, and controlling clinical trials. This regulation was enacted on June 30th, 2017. Other rules and regulations make MA 0075-2017 enforceable. The Constitution of the Republic of Ecuador, in subparagraph d), 3, of Section 66, prohibits using genetic material and scientific experimentation that violates human rights. Every person without discrimination has, concerning health, the…

Marketing, Manufacturing, Packaging & Labelling: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. What is the authorization process for the marketing of new drugs, biologics, medical devices, over-the-counter medications, and other medicinal products? The authorization process for marketing new drugs, biologics, medical devices, OTC, and other medicinal products is through a marketing authorization as detailed in question 3 of Chapter 1. 2. What is the authorization process for the marketing of generic versions of these products? The authorization process and requirements for marketing generic versions are the same; the only difference is…

Traditional Medicines and OTC Products: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. What are the regulatory requirements for traditional, herbal, complementary, or alternative medicines and devices? The General Health Law (HL) and its regulations govern traditional, complementary, and alternative medicines. These medicines are known as natural, whose active ingredients are formed by any part of natural medicinal resources or combinations thereof, such as crude drugs, extracts, or recognized pharmaceutical forms used for therapeutic purposes. These will not be considered processed natural products for medicinal use if the natural resource for medicinal…

Product Liability: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. What types of liability are recognized in your jurisdiction? In general terms, liability arises from the Civil and Criminal Codes, and it is personal responsibility for actions or omissions. However, the Consumer Protection Law establishes that civil damages may be claimed in case of damages caused by a defective or damaged product, where the manufacturers, importers, distributors, sellers, or whoever may have put their trademark on the goods are responsible. Those jointly liable may repeat the action against the…

Patents & Trademarks: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. What are the basic requirements to obtain patent and trademark protection? Any sign distinguishing goods and services on the market shall constitute a mark. Signs capable of graphic representation shall be eligible for registration as a mark; in particular, the shape of a product, its packaging, or wrapping may constitute a trademark. Patents will be granted for inventions, whether for goods or processes, in all areas of technology, provided that they are new, involve inventiveness, and are industrially applicable.…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Ecuador

01/10/2024

Corral Rosales

Ecuador

Cannabinoid Drugs 1. Are Cannabinoid Drugs authorized in your country? On September 17, 2019, Congress approved a reform of the Criminal Code, which reforms included the decriminalization of possession of drugs that contain cannabis or derivatives as their active ingredient for therapeutic, palliative, or medicinal use or the practice of alternative medicine. In addition, the Law of Control and Prevention of the Use of Drugs was amended, excluding non-psychoactive or hemp cannabis from control, extended to the cannabis plant or…

Orphan Drugs and Rare Diseases: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. What is the definition of Rare Diseases in your country? Our law states a specific definition for rare diseases, which is the following: They are mainly considered life-threatening or debilitating in the long term. They have low prevalence and high complexity and constitute many diseases. They are characterized by being chronic and disabling. Their therapeutic resources are limited and expensive; some are in the experimental stage. 2. Does the designation of ‘Orphan Drug’ exist in your country? (Does…

Localization: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. Are there any rules or regulations requiring and/or encouraging localization in your country? What is the legal framework defining these localization rules and policies? New productive investments made from January 2022, including those in the pharmaceutical sector, may be eligible for tax benefits. Investors generally benefit from a 3-point reduction in the corporate income tax rate. Additionally, if the investor enters into an investment agreement, they will benefit from a 5-point reduction in the corporate income tax rate, exemptions…

Biosimilars and Biologics: Ecuador

01/10/2024

Corral Rosales

Ecuador

1. Are biosimilar medicines considered the same as generic medicines in your country? No, the generic term is used only for medicines made by chemical synthesis, and the term biosimilar is used for medicines of biological origin. A biosimilar medicine is similar in quality, safety, and efficacy to the reference biological medicine. It must demonstrate its equivalent capacity to the reference biological medicine through its comparability. 2. Are all biologic medicines, including biosimilar medicines, patentable in your country? All…

Ecuador’s Emerging Cannabis and Hemp Industry

27/05/2021

Corral Rosales

Ecuador

The cannabis and hemp industry is an emerging new industry in Ecuador with the Reform of the Criminal Law, enacted on June 21st, 2020. Included among the reforms is the decriminalization of possession of drugs containing cannabis or derivatives as their active ingredient for therapeutic, palliative, or medicinal use, or for the practice of alternative medicine. In addition, the Law of Control and Prevention of the use of Drugs has been amended, excluding non-psychoactive or hemp cannabis from control,…